FULGENT GENETIC Revenue, Profits - FLGT Annual Income Statement

Add to My Stocks
$4.19 $0.27 (6.05%) FLGT stock closing price Jun 22, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the FULGENT GENETIC stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 18.27M to 18.73M and how operating and non operating activities have impacted the FLGT stock. The operating expenses as shown in the FULGENT GENETIC profit and loss statement for 2017 total to $13.65M. This line item shows that the operating expenses has increased compared with last year. Also check: FULGENT GENETIC assets and FULGENT GENETIC free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec2017201620152014
FULGENT GENETIC Revenues or Net Sales
Cost Of Goods Sold (COGS)8.55M6.72M5.06M-
Research & Development Expense4.22M3.55M4.43M-
Selling General & Admin Expense9.43M7.07M5.08M-
Income Before Depreciation Depletion Amortization-3.48M--5.01M-0.99M
Depreciation Depletion Amortization----
Non Operating Income--5.38M--
Interest Expense----
Provision for Income Taxes-1.01M---
Investment Gains Losses-0.52M---
Other Income----
Income Before Extraordinaries & Disc Operations-2.51M-5.38M-4.98M-0.99M
Extraordinary Items & Discontinued Operations---3.32M-3.29M
FULGENT GENETIC Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS17.74M---
Average Shares used to compute Basic EPS17.74M---
Income Before Nonrecurring Items-2.03M---
Income from Nonrecurring Items-0.63M---
FULGENT GENETIC Earnings Per Share Basic Net
FULGENT GENETIC Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.11---
Preferred Dividends Acc Pd----
Dividends Common----
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.

The key things to look for in an income statement while doing FULGENT GENETIC stock analysis are:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $18.73M for this year of 2017. Our FULGENT GENETIC revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-2.51M for FULGENT GENETIC for 2017. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the FLGT income statement, one can check the FULGENT GENETIC historical stock prices to check how the price has moved with time.

FULGENT GENETIC Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield